Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2025 04:22 ET | Source: Research and Markets

Thyroid Cancer Drugs Industry and Companies Analysis Report 2025: A $2.2 Billion Landscape by 2029

Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Market Report 2025" has been added to ResearchAndMarkets.com's offering. The thyroid cancer drugs market has demonstrated...
February 10, 2025 06:28 ET | Source: Research and Markets

Doxorubicin Global Industry Report 2025 - Doxorubicin Market Projected to Reach US$1.7 Billion by 2030

Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Doxorubicin was valued at...
January 13, 2025 11:54 ET | Source: Research and Markets

Liposomal Doxorubicin Market Research and Forecast Report 2024-2032: Growing Investments and Collaborations, Personalised Medicine Trends, Market Penetration in Emerging Economies

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global liposomal...
November 07, 2024 08:04 ET | Source: Research and Markets

Liposomal Doxorubicin Market Report 2024-2032: Innovative Liposomal Formulations Pave the Way for Safer and More Effective Cancer Treatments

Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global liposomal...
September 30, 2024 05:50 ET | Source: Research and Markets

$1.89 Bn Liposomal Doxorubicin Markets, 2024-2030: Focus on Doxil/Caelyx, Lipodox, and Myocet

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product, By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer), By...
July 03, 2024 08:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc.

NEWARK, Del, July 03, 2024 (GLOBE NEWSWIRE) -- The liposomal doxorubicin market is estimated to be worth USD 1,281.3 Million in 2024 and is projected to be valued at USD 2,367.5 Million in 2034....
December 16, 2021 08:43 ET | Source: The Insight Partners

Liposome Drug Delivery Market Size Worth $6,992.95 Million, Globally, by 2027 at 8.8% CAGR - Exclusive Report by The Insight Partners

New York, Dec. 16, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Liposomal...